Key result
This review provides practical recommendations for the preprocedure management of new anticoagulants and antiplatelet agents in patients undergoing radiology interventions.
Why the study?
How should new anticoagulation and antiplatelet agents be managed in patients undergoing radiology interventions?
How should new anticoagulation and antiplatelet agents be managed in patients undergoing radiology interventions?
Answers are grounded in this paper and cite their sources.
This review provides practical guidance for radiologists on managing newer anticoagulation and antiplatelet agents prior to interventional procedures.
OBJECTIVE: New medications are available for prophylaxis of deep venous thrombosis, the treatment of venous thromboembolism, and also to reduce the risk of acute coronary syndrome and stroke. The purpose of this review is to provide the radiologist a practical and succinct summary of the new anticoagulation and antiplatelet medications and how to manage these medications in patients who are in need of a radiology intervention. CONCLUSION: This article provides recommendations for preprocedure management of new anticoagulants and antiplatelet agents in patients undergoing radiology intervention.
No takes yet. Share an insight, caveat, or question.
Ho et al. (2008) conducted a review in Patients undergoing radiology intervention requiring anticoagulation or antiplatelet management. New anticoagulation and antiplatelet agents was evaluated. This review provides practical recommendations for the preprocedure management of new anticoagulants and antiplatelet agents in patients undergoing radiology interventions.
Synapse has enriched 10 related papers. Consider them for comparative context: